BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 22498938)

  • 21. Patients with atypical hyperplasia of the endometrium should be treated in oncological centers.
    Antonsen SL; Ulrich L; Høgdall C
    Gynecol Oncol; 2012 Apr; 125(1):124-8. PubMed ID: 22198048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hysteroscopic diagnosis and follow-up of adenomatous hyperplasia and therapeutic consequences].
    Schmidt T; Römer T; Schwesinger G; Lorenz G
    Zentralbl Gynakol; 1997; 119(1):12-5. PubMed ID: 9133142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accuracy of preoperative endometrial sampling diagnosis of FIGO grade 1 endometrial adenocarcinoma.
    Leitao MM; Kehoe S; Barakat RR; Alektiar K; Gattoc LP; Rabbitt C; Chi DS; Soslow RA; Abu-Rustum NR
    Gynecol Oncol; 2008 Nov; 111(2):244-8. PubMed ID: 18752842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Thin-layer cytology in endometrial diagnosis].
    Buccoliero AM; Caldarella A; Noci I; Borri P; Giachi M; Borrani E; Taddei GL
    Pathologica; 2003 Aug; 95(4):179-84. PubMed ID: 14577201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic criteria for distinguishing endometrial adenocarcinoma from complex atypical endometrial hyperplasia.
    Mittal K; Salem A; Lo A
    Hum Pathol; 2014 Jan; 45(1):98-103. PubMed ID: 24182562
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thin-layer cytology and histopathology in the evaluation of abnormal uterine bleeding.
    Garcia F; Barker B; Davis J; Shelton T; Harrigill K; Schalk N; Meyer J; Hatch K
    J Reprod Med; 2003 Nov; 48(11):882-8. PubMed ID: 14686021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The diagnosis of endometrial hyperplasia on curettage: how reliable is it?
    Obeidat B; Mohtaseb A; Matalka I
    Arch Gynecol Obstet; 2009 Apr; 279(4):489-92. PubMed ID: 18679697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The value of curettage in diagnosis of endometrial hyperplasia.
    Xie X; Lu WG; Ye DF; Chen HZ; Fu YF
    Gynecol Oncol; 2002 Jan; 84(1):135-9. PubMed ID: 11748989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The management of endometrial hyperplasia: an evaluation of current practice.
    Clark TJ; Neelakantan D; Gupta JK
    Eur J Obstet Gynecol Reprod Biol; 2006 Apr; 125(2):259-64. PubMed ID: 16246481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of finding an endometrial cancer when atypical hyperplasia was incidentally diagnosed on hysteroscopic resection products.
    Agostini A; Cravello L; Shojai R; Schaeffer V; Bretelle F; Roger V; Blanc B
    Eur J Obstet Gynecol Reprod Biol; 2002 Jun; 103(1):58-9. PubMed ID: 12039465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endometrial cancer in patients with preoperative diagnosis of atypical endometrial hyperplasia.
    Merisio C; Berretta R; De Ioris A; Pultrone DC; Rolla M; Giordano G; Tateo S; Melpignano M
    Eur J Obstet Gynecol Reprod Biol; 2005 Sep; 122(1):107-11. PubMed ID: 16154046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histopathologic consistency between endometrial hyperplasia diagnosis from endometrial curettage and pathologic diagnoses from hysterectomy specimens.
    Jesadapatrakul S; Tangjitgamol S; Manusirivitaya S
    J Med Assoc Thai; 2005 Oct; 88 Suppl 2():S16-21. PubMed ID: 17722313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atypical endometrial hyperplasia: grounds for possible misdiagnosis of endometrial adenocarcinoma.
    Valenzuela P; Sanz JM; Keller J
    Gynecol Obstet Invest; 2003; 56(3):163-7. PubMed ID: 14534372
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [An analysis on the clinicopathological characteristics of 79 cases atypical endometrial hyperplasia].
    Wang ZQ; Yang XQ; Wang JL; Xie JL; Shen DH; Wei LH
    Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):19-23. PubMed ID: 21429429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnosis and follow-up of atypical hyperplasia of corpus endometrium--a critical methodological investigation.
    Geppert M; Smyczek-Gargya B; Menton M
    Zentralbl Gynakol; 1993; 115(11):492-4. PubMed ID: 8296494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Difficulties and mistakes in the diagnosis of atypical endometrial hyperplasia].
    Kxmel'nitskaia NM; Neĭshtadt EL; Khalimdzhanov ZK
    Arkh Patol; 2006; 68(6):39-42. PubMed ID: 17290894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endometrial brush biopsy. An accurate outpatient method of detecting endometrial malignancy.
    Wu HH; Casto BD; Elsheikh TM
    J Reprod Med; 2003 Jan; 48(1):41-5. PubMed ID: 12611094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of histological types of endometrial cancer by endometrial cytology.
    Okadome M; Saito T; Nishiyama N; Ariyoshi K; Shimamoto K; Shimada T; Kodama K; Imamura S; Nishiyama K; Taguchi K
    J Obstet Gynaecol Res; 2014 Jul; 40(7):1931-9. PubMed ID: 25056473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of ARID1A expression in endometrial samplings is associated with the risk of endometrial carcinoma.
    Yen TT; Miyamoto T; Asaka S; Chui MH; Wang Y; Lin SF; Stone RL; Fader AN; Asaka R; Kashima H; Shiozawa T; Wang TL; Shih IM; Tanner EJ
    Gynecol Oncol; 2018 Sep; 150(3):426-431. PubMed ID: 30126589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic markers for detection of coexistent carcinoma in high-risk endometrial hyperplasia.
    Ørbo A; Moe BT; Arnes M; Pettersen I; Larsen K; Eggen T; Myrmel K; Hanssen K
    Anticancer Res; 2010 Nov; 30(11):4649-55. PubMed ID: 21115919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.